[Research Report] The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Market Insights and Analyst View:
Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality. The market is driven by the factors such drug shortage crisis across the globe, benefits associated with compounded medications and increasing adoption of customized medicine (Personalized medicine). However, product recalls and stringent regulatory requirements will likely hinder the compounding pharmacies market growth during the forecast period.
Growth Drivers and Challenges:
A compounding pharmacy or specialty pharmacy makes drugs recommended by doctors for patients that are not commercially available. The demand for compounding pharmacy is growing due to its various associated benefits. For instance, compounding pharmacy is highly recommended to patients with allergies or to those who are young and need a small dosage of a particular medication. Additionally, pharmacists can alter ingredients if patients are lactose intolerant, glucose intolerant, or allergic to the commercial drug's unnecessary dye. Moreover, pharmacists can lessen the dosage for children or can add flavor for children and double the dose for adults depending on their needs. For patients who are delicate to oral administration, one can change pill formulation into a liquid for the ease of taking it. Compounding pharmacists can get access to medications that have been discontinued to patients who still depend on them. They can recreate the pharmaceutical-based ingredients to retain patients’ health.
Currently, compounding pharmacists are getting access to the highest quality ingredients, the latest research, techniques, and quality control rules to meet their patient’s needs. Further, a compounding pharmacy can create alternative dosage forms when patients face difficulties in swallowing pills. As per the patient and medication type, compounding pharmacies can make the act of taking medicines less difficult. For instance, certain medications can be reformulated into topical solutions to be implemented onto the skin and absorbed into the bloodstream. These benefits are leading to an increase in demand for compounding pharmacies.
Moreover, the major players in the market such as Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc. are anticipated to provide significant growth opportunities in the worldwide compounding pharmacies market during the forecasted period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Compounding Pharmacies Market: Strategic Insights
Market Size Value in US$ 9,442.8 Million in 2020 Market Size Value by US$ 14,995.1 Million by 2028 Growth rate CAGR of 6.1% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Compounding Pharmacies Market: Strategic Insights
| Market Size Value in | US$ 9,442.8 Million in 2020 |
| Market Size Value by | US$ 14,995.1 Million by 2028 |
| Growth rate | CAGR of 6.1% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Compounding Pharmacies Market” is segmented based on product, therapeutic area, and geography. Based on product was segmented into oral medications, topical medications, suppositories, and others. Based on therapeutic area, the compounding pharmacies market has been segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The compounding pharmacies market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
Segmental Analysis:
Based on product, is segmented into oral medications, topical medications, suppositories, and others. In 2020, the oral medications segment held a larger share of the market. However, the topical medications segment is anticipated to register the highest CAGR in the market during the forecast period. Oral administration is a route of administration and it is taken through the mouth. They come in different forms like solid tablets, capsules, chewable tablets, or lozenges that are to be swallowed whole or sucked or as drinkable liquids such as syrups, drops or solutions. Sometimes the drug is consumed by the lining of the mouth, like is the case with lozenges. In most cases, oral medication ingredients don't enter the bloodstream until they enter the stomach or bowel. For example, some active ingredients like laxatives or contrast agents aren't meant to penetrate the bloodstream in large quantities at all. Along with the benefits, there are some restraining factors such as about 9% of children cannot swallow a small oral tablet, as they face some common barriers to effective swallowing, such as developmental stage, fear, anxiety, and intolerance to unpleasant flavors. At the same time, children aged 6–11 years can swallow a small oral tablet with education by a pharmacist or practitioner.
Based on therapeutic area, the compounding pharmacies market has been segmented into pain medications, hormone replacement therapies, dermatological applications, and others. In 2020 the pain medications segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate of CAGR during the coming years. Pain is the most obvious symptom for which patients explore medical help. Acute pain can easily grow into chronic pain, which later becomes difficult to treat. Commercially convenient pain relief medications can treat chronic conditions such as arthritis, fibromyalgia, migraine, and other nerve and muscle pain; however, these medications can grow undesired side effects such as dizziness, drowsiness, or stomach irritation. Therefore, many patients seek a more suitable solution through pharmacy compounding. Compounding is the art and science of developing customized medications for patients. Pharmacy compounding allows patients customized options for pain medication. It provides relevant advantages to those for whom pain management has become a way of life. Dosage forms of pain medication may include topical creams, topical ointments, topical gels, suppositories, rectal suppositories, vaginal, troches, oral solutions, etc. Thus, pain management are contributing to the compounding pharmacies market and are expected to continue the trend during the forecast period.
Regional Analysis:
Based on geography, the compounding pharmacies market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America compounding pharmacies market has been analysed based on three major countries — the US, Canada, and Mexico. The US compounding pharmacies market is estimated to hold the largest compounding pharmacies market share during the forecast period. The compounding pharmacies market growth in the US is attributed to the to the Market players are adopting organic and inorganic strategies for the market development. For instance, In Jan. 2021, Nephron Pharmaceuticals Corporation launched a brand-new syringe presentation under the highly successful Nephron 503B Outsourcing Facility operation. The Cyclic Olefin Copolymer syringe (COC) has a glass-like appearance but is break-resistant and lightweight. COC syringes are suitable for a variety of medications, including highly viscous drugs and provide for extended product shelf-life. Owing to the factors mentioned above in the country is expected to witness fast growth during the forecast period.
UK is the second leading region in the global compounding pharmacies market. Germany is holding the largest share in the Europe compounding pharmacies market during the forecast period due to the factors such as increase in the effectiveness of compounding drugs, which are likely to be the significant factors driving the growth of compounding pharmacies market in this region. The UK is moving ahead of the modern healthcare industry. The increasing geriatric population is the primary factor driving the growth of the UK compounding pharmacies industry. The population's lifespan has improved as a result of the change from high to low fertility and the shift in leading causes of death from infectious and bacterial diseases to chronic illnesses and noncommunicable diseases. Furthermore, the low cost of compounding pharmacies will benefit market growth in the coming years. The increased proportion of people approaching advanced age, and the growing need to look younger, would drive up demand for anti-aging products such as bioidentical hormone replacement therapy for women, human growth hormone, and high-quality dermatological products mainly manufactured in compounding pharmacies.
Furthermore, the ease and advantages provided by compounded drugs would be another factor influencing business development. Individuals that need treatment of an intensity not presently available on the market, and medications that are not currently widely available, are served by highly advanced compounding pharmacies. The potential of compounding pharmacies to expand the supply of difficult-to-find drugs, such as hormone therapy, would aid demand growth. Owing to the factors mentioned above in the country, UK compounding pharmacies market is expected to witness growth during the forecast period.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global compounding pharmacies market are listed below:
- B. Braun Melsungen AG and Grifols form strategic partnership to enhance compounding pharmacy production output and services for hospitals. Grifols is a leading producer of plasma-derived medicines and has compounding centres in U.S.
- Triangle Compounding Pharmacy has launched compounded hand sanitizer to fight with the COVID-19 pandemic. Triangle Compounding Pharmacy is the first to provide pharmaceutical-grade hand sanitizer in U.S.
Compounding Pharmacies Market Report Scope
Competitive Landscape and Key Companies:
Some of the prominent players operating in the compounding pharmacies market Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc. among others among others are the leading companies operating in the compounding pharmacies market. These companies focus on various growth strategies such as collaboration, product launches, business expansions, agreements among others to retain its position in the global market. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their compounding pharmacies market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Therapeutic Area and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The factors that are driving growth of the market are drug shortage crisis across the globe, benefits associated with compounded medications and increasing adoption of customized medicine (Personalized medicine).
The compounding pharmacies market majorly consists of the players such as Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc.
Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality. Additionally, as per law, compounding drugs does not include making copies of commercially available drug products. Compounding pharmacists can make flavored drugs in different dosage forms, such as liquids, topical creams, suppositories, transdermal gels, or other dosage forms suitable for patient's unique needs.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Compounding Pharmacies Market – By Product
1.3.2 Global Compounding Pharmacies Market – By Therapeutic Area
1.3.3 Global Compounding Pharmacies Market– By Geography
2. Compounding Pharmacies Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Compounding Pharmacies Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Compounding Pharmacies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Drug Shortage Crisis Across the World
5.1.2 Benefits of Compounded Medications
5.1.3 Increasing Adoption of Customized Medicine (Personalized Medicine)
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Growing Demand for Compounding Pharmacy During COVID-19
5.4 Future Trends
5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.5 Impact Analysis
6. Compounding Pharmacies Market– Global Analysis
6.1 Global Compounding Pharmacies Market Revenue Forecast and Analysis
6.2 Global Compounding Pharmacies Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Compounding Pharmacies Market Analysis – By Product
7.1 Overview
7.2 Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
7.3 Oral Medications
7.3.1 Overview
7.3.2 Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Topical Medications
7.4.1 Overview
7.4.2 Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Suppositories
7.5.1 Overview
7.5.2 Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8. Compounding Pharmacies Market – By Therapeutic Area
8.1 Overview
8.2 Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
8.3 Pain Medications
8.3.1 Overview
8.3.2 Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hormone Replacement Therapies
8.4.1 Overview
8.4.2 Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Dermatological Applications
8.5.1 Overview
8.5.2 Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9. Compounding Pharmacies Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028
9.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.1.3 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.4 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.4.1 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.4.2 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.5 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.5.1 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.5.2 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.5.3 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.1.6 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.6.1 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.6.2 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.1.6.3 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028
9.2.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.1.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.1.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.2.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3.1 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3.2 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.3.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.4 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.4.1.1 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.4.2 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.4.3 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.4.4 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.5.2 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.6 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.6.1 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.6.2 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.6.3 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.7 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.8 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.8.1 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.8.2 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.2.9 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.10 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.10.1 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.2.10.2 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.3 Asia Pacific: Compounding Pharmacies Market
9.3.1 Overview
9.3.2 Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia Pacific: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.4 Asia Pacific: Compounding Pharmacies Market, by Therapeutic Area – 2019–2028 (USD Million)
9.3.5 Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)
9.3.6 China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.1 China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.2 China: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.6.3 China: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.3.7 Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.7.1 Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.7.2 Japan: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.7.3 Japan: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.3.8 India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.8.1 India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.8.2 India: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.8.3 India: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.3.9 South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.1 South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.2 South Korea: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.9.3 South Korea: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.3.10 Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.1 Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.2 Australia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)
9.3.10.3 Australia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.3.11 Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.11.1 Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.3.11.2 Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
9.3.11.3 Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
9.4 East & Africa: Compounding Pharmacies Market
9.4.1 Overview
9.4.2 Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Middle East and Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)
9.4.4 Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.4.5 Middle East and Africa: Compounding Pharmacies Market, by Country, 2020& 2028 (%)
9.4.6 UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.6.1 UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.6.2 UAE: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)
9.4.6.3 UAE: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.4.7 Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.7.2 Saudi Arabia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)
9.4.7.3 Saudi Arabia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.4.8 South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.8.1 South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.8.2 South Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)
9.4.8.3 South Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.4.9 Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.4.9.1 Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
9.4.9.2 Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
9.4.9.2.1 Rest of Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)
9.5 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028
9.5.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.1.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.1.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.5.3 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.4 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.4.1 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.4.2 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.5 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.6 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.6.1 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.6.2 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
9.5.7 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.8 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.8.1 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
9.5.8.2 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
10. Impact Of COVID-19 Pandemic on Global Compounding Pharmacies Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of The World: Impact Assessment of COVID-19 Pandemic
11. Compounding Pharmacies Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fagron, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Triangle Compounding Pharmacy
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B.Braun Melsungen AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PharMEDium Healthcare Holdings, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Avella specialty pharmacy
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Vertisis Custom Pharmacy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 US Compounding Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Elixir Compounding Pharmacy
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. A few drugs that are in short supply are listed below:
Table 2. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 4. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 5. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 6. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 7. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 8. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 9. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 10. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 11. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 12. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 13. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 14. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 15. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 16. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 18. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 19. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 20. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 21. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 22. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 23. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 24. Asia Pacific Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 25. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 26. China Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 27. China Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 28. Japan Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 29. Japan Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 30. India Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 31. India Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 32. South Korea Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 33. South Korea Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 34. Australia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 35. Australia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 38. Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)
Table 39. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 40. UAE Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)
Table 41. UAE Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 42. Saudi Arabia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)
Table 43. Saudi Arabia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 44. South Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)
Table 45. South Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 47. Rest of Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)
Table 48. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 49. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 50. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 51. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 52. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 53. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 54. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 55. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)
Table 56. Organic Developments Done By Companies
Table 57. Inorganic Developments Done By Companies
Table 58. Glossary of Terms, Compounding Pharmacies Market
LIST OF FIGURES
Figure 1. Compounding Pharmacies Market Segmentation
Figure 2. Compounding Pharmacies Segmentation, By Region
Figure 3. Global Compounding Pharmacies Market Overview
Figure 4. Oral Medications Held Largest Share of Product Segment in Compounding Pharmacies Market
Figure 5. North America to Show Remarkable Growth During Forecast Period
Figure 6. Compounding Pharmacies Market, by Geography (US$ Million)
Figure 7. Global Compounding Pharmacies Market– Leading Country Markets (US$ Million)
Figure 8. Global Compounding Pharmacies Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Compounding Pharmacies Market Impact Analysis of Drivers and Restraints
Figure 15. Global Compounding Pharmacies Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Compounding Pharmacies Market– By Geography Forecast and Analysis – 2020- 2028
Figure 17. Market Positioning of Key Players in Global Compounding Pharmacies Market
Figure 18. Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)
Figure 19. Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)
Figure 24. Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 29. North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)
Figure 33. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Europe Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 35. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 37. UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 43. Asia Pacific: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)
Figure 44. Asia Pacific Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Million)
Figure 45. China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Middle East & Africa: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)
Figure 52. Middle East and Africa Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Millions)
Figure 53. UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. South and Central America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)
Figure 58. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
Figure 64. Impact of COVID-19 Pandemic in European Country Markets
Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 66. Impact Of COVID-19 Pandemic in Rest of The World Market
Figure 67. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Compounding Pharmacies Market
- Fagron, Inc.
- Elixir Compounding Pharmacy
- Avella specialty pharmacy
- B. Braun Melsungen AG
- PharMEDium Healthcare Holdings, Inc.
- Fresenius Kabi AG
- Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd
- Triangle Compounding Pharmacy
- Vertisis Custom Pharmacy
- US Compounding Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Compounding Pharmacies Market
Mar 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Mar 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Mar 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Mar 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Mar 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Mar 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Mar 2021
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For